Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 292

1.

A model to predict pathologic complete response of axillary lymph nodes to neoadjuvant chemo(immuno)therapy in patients with clinically node-positive breast cancer.

Schipper RJ, Moossdorff M, Nelemans PJ, Nieuwenhuijzen GA, de Vries B, Strobbe LJ, Roumen RM, van den Berkmortel F, Tjan-Heijnen VC, Beets-Tan RG, Lobbes MB, Smidt ML.

Clin Breast Cancer. 2014 Oct;14(5):315-22. doi: 10.1016/j.clbc.2013.12.015. Epub 2014 Jan 3.

PMID:
24548732
2.

Prognostic Nomogram for Prediction of Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy in Cytologically Proven Node-Positive Breast Cancer.

Kim JY, Park HS, Kim S, Ryu J, Park S, Kim SI.

Medicine (Baltimore). 2015 Oct;94(43):e1720. doi: 10.1097/MD.0000000000001720.

3.

Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms?

Biolchini F, Vicentini M, Di Felice E, Giovanardi F, Antonio L, Giorgi Rossi P, Annessi V.

Tumori. 2015 May-Jun;101(3):298-305. doi: 10.5301/tj.5000281. Epub 2015 Apr 2.

PMID:
25838248
4.
5.

Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.

Gajdos C, Tartter PI, Estabrook A, Gistrak MA, Jaffer S, Bleiweiss IJ.

J Surg Oncol. 2002 May;80(1):4-11.

PMID:
11967899
6.

Can nomograms predict non-sentinel lymph node metastasis after neoadjuvant chemotherapy in sentinel lymph node-positive breast cancer patients?

Unal B, Gur AS, Ahrendt G, Johnson R, Bonaventura M, Soran A.

Clin Breast Cancer. 2009 May;9(2):92-5. doi: 10.3816/CBC.2009.n.017.

PMID:
19433389
7.

Sentinel lymph node biopsy is a reliable method for lymph node evaluation in neoadjuvant chemotherapy-treated patients with breast cancer.

Koslow SB, Eisenberg RE, Qiu Q, Chen Z, Swistel A, Shin SJ.

Am Surg. 2014 Feb;80(2):171-7.

PMID:
24480218
8.

Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patients.

Gimbergues P, Abrial C, Durando X, Le Bouedec G, Cachin F, Penault-Llorca F, Mouret-Reynier MA, Kwiatkowski F, Maublant J, Tchirkov A, Dauplat J.

Ann Surg Oncol. 2009 Jul;16(7):1946-51. doi: 10.1245/s10434-009-0400-1. Epub 2009 May 2.

PMID:
19408057
9.

Non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node: validation of five nomograms and development of a new predictive model.

Lombardi A, Maggi S, Lo Russo M, Scopinaro F, Di Stefano D, Pittau MG, Tiberi S, Amanti C.

Tumori. 2011 Nov-Dec;97(6):749-55. doi: 10.1700/1018.11092.

10.

Early assessment of axillary response with ¹⁸F-FDG PET/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla.

Koolen BB, Valdés Olmos RA, Wesseling J, Vogel WV, Vincent AD, Gilhuijs KG, Rodenhuis S, Rutgers EJ, Vrancken Peeters MJ.

Ann Surg Oncol. 2013 Jul;20(7):2227-35. doi: 10.1245/s10434-013-2902-0. Epub 2013 Mar 1.

PMID:
23456316
11.

Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison.

Kuo YL, Chen WC, Yao WJ, Cheng L, Hsu HP, Lai HW, Kuo SJ, Chen DR, Chang TW.

Int J Surg. 2013;11(7):538-43. doi: 10.1016/j.ijsu.2013.05.005. Epub 2013 May 22.

12.

International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer.

Meretoja TJ, Leidenius MH, Heikkilä PS, Boross G, Sejben I, Regitnig P, Luschin-Ebengreuth G, Žgajnar J, Perhavec A, Gazic B, Lázár G, Takács T, Vörös A, Saidan ZA, Nadeem RM, Castellano I, Sapino A, Bianchi S, Vezzosi V, Barranger E, Lousquy R, Arisio R, Foschini MP, Imoto S, Kamma H, Tvedskov TF, Kroman N, Jensen MB, Audisio RA, Cserni G.

J Natl Cancer Inst. 2012 Dec 19;104(24):1888-96. doi: 10.1093/jnci/djs455. Epub 2012 Nov 1.

PMID:
23117131
13.

Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer.

Kuerer HM, Newman LA, Buzdar AU, Hunt KK, Dhingra K, Buchholz TA, Binkley SM, Ames FC, Feig BW, Ross MI, Hortobagyi GN, Singletary SE.

Am J Surg. 1998 Dec;176(6):502-9.

PMID:
9926779
14.

Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.

Gur AS, Unal B, Johnson R, Ahrendt G, Bonaventura M, Gordon P, Soran A.

J Am Coll Surg. 2009 Feb;208(2):229-35. doi: 10.1016/j.jamcollsurg.2008.10.029. Epub 2008 Dec 18.

PMID:
19228534
15.

Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation.

Newman EA, Sabel MS, Nees AV, Schott A, Diehl KM, Cimmino VM, Chang AE, Kleer C, Hayes DF, Newman LA.

Ann Surg Oncol. 2007 Oct;14(10):2946-52. Epub 2007 May 19.

PMID:
17514407
16.

Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study.

Coutant C, Rouzier R, Fondrinier E, Marchal F, Guillemin F, Seince N, Rodrigues A, Darai E, Uzan S, Barranger E.

Breast Cancer Res Treat. 2009 Feb;113(3):537-43. doi: 10.1007/s10549-008-9967-7. Epub 2008 Mar 14.

PMID:
18340527
17.

Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.

Ouldamer L, Arbion F, Balagny A, Fourquet F, Marret H, Body G.

Breast. 2013 Oct;22(5):787-92. doi: 10.1016/j.breast.2013.02.004. Epub 2013 Mar 7.

PMID:
23473772
18.

Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation.

Takei H, Yoshida T, Kurosumi M, Inoue K, Matsumoto H, Hayashi Y, Higuchi T, Uchida S, Ninomiya J, Kubo K, Oba H, Nagai S, Tabei T.

Int J Clin Oncol. 2013 Jun;18(3):547-53. doi: 10.1007/s10147-012-0418-4. Epub 2012 May 16.

PMID:
22588780
19.

Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.

Kuerer HM, Newman LA, Buzdar AU, Dhingra K, Hunt KK, Buchholz TA, Binkley SM, Strom EA, Ames FC, Ross MI, Feig BW, McNeese MD, Hortobagyi GN, Singletary SE.

Cancer J Sci Am. 1998 Jul-Aug;4(4):230-6.

PMID:
9689981
20.

A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes.

Canavese G, Bruzzi P, Catturich A, Vecchio C, Tomei D, Del Mastro L, Carli F, Guenzi M, Lacopo F, Dozin B.

Eur J Surg Oncol. 2014 Jul;40(7):835-42. doi: 10.1016/j.ejso.2014.03.005. Epub 2014 Mar 16.

PMID:
24684810

Supplemental Content

Support Center